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Mitochondrial DNA (mtDNA) deletions have been investigated in a number of neurodegenerative diseases. This study aimed to inves-
tigate the characteristics of mtDNA deletions found in single substantia nigra neurons from three patient groups: controls, Parkinson
disease patients, and a patient with Parkinsonism due to multiple mtDNA deletions.We have identiﬁed 89 deletions from these neurons
and examined the breakpoint characteristics of them. There was no difference in the types of mtDNA deletions detected in these
neurons. These results suggest that the mechanism leading to the formation of these deletions in these three distinct groups could
be the same.Recently, very high levels of somatic mitochondrial DNA
(mtDNA) deletions (z50%) have been described in
substantia nigra neurons from both elderly control sub-
jects and patients with Parkinson disease (PD [MIM
168600]).1,2 Although this is one of the most striking
examples of high levels of somatic mtDNA mutations in
human aging, somatic mtDNA mutations have been iden-
tiﬁed in several different tissues from elderly humans. In
the substantia nigra and other tissues, these mtDNAmuta-
tions clonally expand within individual cells, and if high
levels of an individual mutation are reached, then this
results in a biochemical defect. This defect is detected by
the histochemical presence of low activity of cytochrome
c oxidase (COX) in single cells, an enzyme complex with
three subunits encoded by the mitochondrial genome.3,4
An important feature of the analysis of aging postmitotic
tissues is that in the COX-deﬁcient cells the clonally
expanded mtDNA mutations are usually (if not exclu-
sively) deletions of the mitochondrial genome. Important
questions are raised about the mechanism both of mtDNA
deletion formation in these postmitotic cells and, once
formed, how they clonally expand to high levels in indi-
vidual cells (often over 60% to cause a biochemical
defect).4 Also, because these somatic mutations and
COX-deﬁcient cells are observed in certain neurodegenera-
tive diseases [e.g., Alzheimer’s disease (AD [MIM 104300])
and PD],1,5 is there a similar mechanism involved? To get
a greater understanding of these mechanisms, we have
looked at the types of mtDNA deletions detected in sub-
stantia nigra neurons from both elderly control subjects
and patients with PD. In addition, we have also studied
substantia nigra neurons from a patient with multiple
deletions in muscle and a mutation in the mitochondrial
polymerase (POLG1) who had Parkinsonism and extensive
COX-deﬁcient neurons and cell loss in the substantia
nigra.228 The American Journal of Human Genetics 82, 228–235, JanuaryThe use of all human tissue has been consented to by the
appropriate Local Research Ethics Committee and con-
forms to the United Kingdom Medical Research Council
(UK MRC) guidelines on the use of tissue in medical re-
search. Frozen midbrain tissue samples were collected
from ﬁve PD cases (mean age 77.4 years, mean postmortem
[PM] delay 27.3 hr), ﬁve age-matched controls (mean age
78.4 years, mean PM delay 24.6 hr), and from a single
patient (age 59) with a multiple-mtDNA-deletion disorder.
This patient presented with progressive external ophthal-
moplegia at age 22 but developed Parkinsonism at age
51.Muscle biopsy from this patient contained 14.5%COX-
deﬁcient muscle ﬁbers and multiple mtDNA deletions.
The substantia nigra of this patient contained 21% COX-
deﬁcient neurons and multiple mtDNA deletions. Serial
transverse frozen midbrain sections were cut from rostral
to caudal at 20 mm thickness.
Mitochondrial dysfunction was detected by sequential
histochemical staining for the activities of COX and
succinate dehydrogenase (SDH). Single neurons were
captured with a Leica laser microdissection microscope
(Leica LMD) and stored at 20C for molecular genetic
analysis.
Total DNA was isolated from single neurons with
a QIAamp DNA Micro Kit (QIAGEN) and eluted in 20 ml
of water. To detect possible mtDNA deletions in individual
cells, we used a two-step long-range polymerase chain re-
action (PCR) strategy (Expand Long Template PCR Sys-
tem, Roche) to amplify a 10 kb fragment spanning the
major arc of the genome. First-round PCR reactions used
1 ml of DNA as template and comprised 13 reaction buf-
fer (Roche), 10 mM each deoxynucleotide triphosphate
(dNTP), 10 mg bovine serum albumin (BSA) (103), 0.75 ml
enzyme mix, and 30 pmol of primer (nt 5855–5875
[according to Cambridge reference sequence] and nt
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were carried out with a GeneAmp PCR System 9600 (Ap-
plied Biosystems) with the following cycling conditions:
3 min at 93C; 10 cycles of 93C for 30 s, 58C for 30 s,
and 68C for 12 min; 20 cycles of 93C for 30 s, 58C
for 30 s, and 68C for 12 min plus 5 s per additional cycle;
and a ﬁnal extension of 11 min at 68C. This reaction
product was then diluted to 1:50, and 1 ml was used as
template in a second round of PCR ampliﬁcation, with
the same reagents as above except the primers used were
nt 6358–6377 and nt 15368–15349 for the generation of
a 9 kb fragment and nt 7272–7293 and nt 13859–13839
for the generation of a 6.5 kb fragment. In view of the
previous observations for a hotspot for deletions at
16070 bp,6,7 we also performed long-range PCR to encom-
pass this region. The PCR conditions were identical to
those described above except the primers used were nt
5855–5875 and nt 129–110 for the ﬁrst round and nt
6358–6377 and nt 019–001 for the second round. Ampli-
ﬁed products were separated through 0.7% agarose gels
containing ethidium bromide and visualized over ultravi-
olet (UV) light. These ampliﬁed products were then gel
extracted with the QIAGEN Gel Extraction Kit per the
manufacturer’s instructions. The concentration of the ex-
tracted DNAwas then measured with a NanoDrop spectro-
photometer. Ampliﬁed samples were puriﬁed (ExoSapIT,
Amersham Pharmacia), sequenced with BigDye (v3.1)
terminator cycle sequencing chemistries on an ABI 3100
Genetic Analyzer (Applied Biosystems), and directly com-
pared to the revised Cambridge reference sequence (rCRS)
with SeqScape software (Applied Biosystems).
We detected a total of 89 mtDNA deletions by using
nested, long-range PCR assays that ampliﬁed between the
regions nt 7293 and nt 13859 (n ¼ 59) and between nt
6377 and nt 019 (n ¼ 30) in individual neurons from the
substantia nigra of three different groups: patients with
PD, age-matched controls, and a patient with multiple-
deletion disorder. In the majority of neurons in which we
were able to identify a long-range PCR product, we never
detected a full-length product (Figure 1). Although long-
range PCR is not quantitative, this result highlights how
frequent mtDNA deletions are within individual neurons.
We detected deletions of various sizes ranging from1763 bp
to 9445 bp within the major arc of the mitochondrial
genome (Tables 1 and 2). All detected deletions resulted
in the loss of both transfer RNA (tRNA) and protein-encod-
ing genes. For the purposes of this report, the breakpoint
closest to the origin of light-strand replication (nt 5721–
5798) was denoted 50 and the breakpoint closest to the
origin of heavy-strand replication was denoted 30. Each
neuron harboured a different mtDNA deletion. Twelve
mtDNA deletions were detected in more than one neuron,
and these deletions were detected in neurons from the
same and different individuals. The 4977 bp ‘‘common’’
deletion was detected a total of seven times in the neurons
studied. We also detected a 7920 bp (nt 6423–14344) and
a 8558 bp (nt 6585–15144) deletion in four neurons
and a 6877 (nt 7114–13992), a 6278 bp (nt 7409–13688),The Amand a 9128 bp (nt 6790–15918) deletion three times
each. Six other deletions were detected in two neurons
each. By using the primers that spanned the 16070 region,
we detected three deletions with a breakpoint within this
region; two were detected in aged neurons with 30 break-
points at nt 16074 and nt 16035, and one was detected
in a neuron from the patient with multiple-deletion disor-
der 30 breakpoint at nt 16071.
Of the deletions that we investigated, 71 out of 89 in-
volved a direct repeat of at least 3 bp. Thirty-seven out of
eighty-nine of the breakpoints involved a perfect repeat,
34 out of 89 had an imperfect repeat, and 18 out of 89
Figure 1. An Agarose Gel Displaying a Typical Long-Range PCR
of Substantia Nigra Neurons
(A) A typical agarose gel displaying the different sized mtDNA
deletions that have been amplified with long-range PCR on DNA
from single neurons. This gel shows the products from a second-
round PCR, and each lane represents a PCR from a single cell. In
some cells, it is possible to detect multiple deletions. Lanes 1, 2,
9, and 10 show deletions detected in a cell from an aged individual,
lanes 5 and 6 show deletions detected in a cell from a PD patient,
lanes 11,12, and 16–21 show deletion detected within cells from
the patient with multiple mtDNA deletions, and lanes 22 and 23
show negative controls. Those cells marked with an * indicate
products from a 9 kb PCR, whereas the remaining lanes are the
product of a 6 kb PCR.
(B) A representation of the positions of the primer pairs used in
this study. Primer pairs C (15896–15877) and H (5855–5875)
were used for the generation of the 10 kb first round PCR, primer
pairs D (15368–15348) and G (6358–6377) the 9 kb second round,
and primer pairs E (13859–13839) and F (7272–7293) the 6 kb sec-
ond round. Primer pairs A (129–110) and H (5855–5875) were used
for the generation of the first-round PCR products for the 16070 bp
assay and primer pairs B (019–001) and G (6358–6377) the second
round products of this assay.erican Journal of Human Genetics 82, 228–235, January 2008 229
Table 1. MtDNA Deletion Breakpoints from Substantia Nigra Neurons with Primers within the Major Arc
Deletion Break Points Repeat 50 Sequence 30 Sequence
Class of
Deletion
Size
(bp)
PD
1 9729–15338 no repeat 50-TCTCTATTTTACCC-30 50-CTATTCTTGCACG-30 Class III 5608
2 7805–13844 50-CCTAG-30 50-CCGCCATCAT(CCTAG)-30 50-ACCTCAACTACCTAA-30 Class I 6038
3 8280–13782 50-CCCCCTCTAC-30 50-CACCCCCTCTA(CCCCCTCTAG)-30 50-(CCCCCTCTAC)CTAAAACTC-30 Class II 5501
4 6423–14344 50-ACCCC-30 50-TCAATATAAA(ACCCC)-30 50-ATCATACTCTTTC-30 I 7920
5 8482–13460 50-ACCTCCCTCACCA-30 50-AAACTACCACCT(ACCTCCCTCACCA)-30 50-TTGGCAGCCTAGCATT-30 I 4977
6 8566–13991 50-TCCTAGACCT-30 50-TGCCCCCACAA(TCCTAGGCCT)-30 50-(TCCTAGACCT)AACCTGACTA-30 II 5424
7 7114–13992 50-CCTAGACCTAACCT-30 50-TCAGGCTACAC(CCTAGACCAAACCT)-30 50-(CCTAGACCTAACCT)GACTAGAAAA-30 II 6877
8 7114–13992 50-CCTAGACCTAACCT-30 50-TCAGGCTACAC(CCTAGACCAAACCT)-30 50-(CCTAGACCTAACCT)GACTAGAAAA-30 II 6877
9 6423–14344 50-ACCCC-30 50-TCAATATAAA(ACCCC)-30 50-ATCATACTCTTTC-30 I 7920
10 9659–11536 50-CATAGTCTA-30 50-AATCACCTGAGCTCAC(CATAGTCTA)-30 50-(CATAGCCTA)CCCCTTCC-30 II 1876
11 8034–11434 50-GAAGCCCCCAT-30 50-TACTCCCGATT(GAAGCCCCCAT)-30 50-CGCTGGGTCAATAGTAC-30 I 3399
12 6423–14344 50-ACCCC-30 50-TCAATATAAA(ACCCC)-30 50-ATCATACTCTTTC-30 I 7920
13 10104–11868 50-GCCTTAC-30 50-AACACCCTCCTA(GCCTTAC)-30 50-CCCCCACTATTAACCT-30 I 1763
14 8482–13460 50-ACCTCCCTCACCA-30 50-AAACTACCACCT(ACCTCC>CTCACCA)-30 50-TTGGCAGCCTAGCATT-30 I 4977
15 8049–14115 no repeat 50-TTCGTATAATAATTAC-30 50-CCCACTCATCCTAACCC-30 III 6065
16 7677–15013 no repeat 50-CCCTCATAATCAT-30 50-ATTCTTTATCTGCCTCTT-30 III 7335
17 8482–13460 50-ACCTCCCTCACCA-30 50-AAACTACCACCT(ACCTCCCTCACCA)-30 50-TTGGCAGCCTAGCATT-30 I 4977
18 8428–15482 50-ACACTATTC-30 50-CCCCCATACTCCTT(ACACTATTC)-30 50-TCACCAGACCTCCTAGG-30 I 7054
19 7409–13688 50-CCCCACCCTAC-30 50-TATATGGATGCC(CCCCACCCTAC)-30 50-TAAACCCCATTAACG-30 I 6278
20 7409–13688 50-CCCCACCCTAC-30 50-TATATGGATGCC(CCCCACCCTAC)-30 50-TAAACCCCATTAACG-30 I 6278
21 7635–15310 50-TCAT-30 50-GACGCTACTTCCCCTA(TCAT)-30 50-TATTGCAGCCCTAGCAAC-30 I 7674
22 8482–13460 50-ACCTCCCTCACCA-30 50-AAACTACCACCT(ACCTCCCTCACCA)-30 50-TTGGCAGCCTAGCATT-30 I 4977
Aged
1 7805–13844 50-CCTAG-30 50-CCGCCATCAT(CCTAG)-30 50-ACCTCAACTACCTAA-30 I 6038
2 6555–14345 50-CCA-30 50-GCAACCTCAACA(CCA)-30 50-TCATACTCTTTCACCC-30 I 7789
3 6437–14077 50-CCATAACCCAA-30 50-CCCCCTG(CCATAACCCAA)-30 50-(CCTCAACCCAA)AAAGGCATA-30 II 7639
4 6427–15269 no repeat 50-AAACCCCCTGC-30 50-CTCACACGATTCTTT-30 III 8841
5 8418–14127 50-TCCT-30 50-TTACCCCCATAC(TCCT)-30 50-AACCCTACTCCTAAT-30 I 5708
6 9924–15194 no repeat 50-GAAGCCGCCGCCT-30 50-CTATCCGCCATCCC-30 III 5269
7 6453–14288 50-CCCCTCT-30 50-TACCAAACG(CCCCTCT)-30 50-CCTTCATAAATTATTC-30 I 7834
8 8408–14118 50-CCC-30 50-ACCATAATTA(CCC)-30 50-ACTCATCCTAACCC-30 I 5709
9 8482–13460 50-ACCTCCCTCACCA-30 50-AAACTACCACCT(ACCTCCCTCACCA)-30 50-TTGGCAGCCTAGCATT-30 I 4977
10 6423–14344 50-ACCCC-30 50-TCAATATAAA(ACCCC)-30 50-ATCATACTCTTTC-30 I 7920
11 6416–14182 50-CAATTATCAATATA-30 50-CACAA(CAATTATCAATATA)-30 50-(CAATTA_CAATATA)TACACCAACAAA-30 II 7765
12 8049–14115 no repeat 50-TTCGTATAATAATTAC-30 50-CCCACTCATCCTAACCC-30 III 6065
13 6476–14146 50-TCCTAATCACA-30 50-CTGATCCG(TCCTAATCACA)-30 50-TAACCTATTCCCCCG-30 I 7669
14 7815–13581 50-CTCATCGC-30 50-CATCCTAGTC(CTCATCGC)-30 50-TACCTCCCTGACAA-30 I 5765
15 7658–15548 50-ATCAAGCCC-30 50-ATCACCTTTCATG(ATCACGCCC)-30 50-(ATCAAGCCC)GAATGATATTT-30 II 7889
16 6585–15144 50-GACC-30 50-CCGGAGGAGGA(GACC)-30 50-(GTCC)TCCCGTGAGGCCAAA-30 II 8558
17 6585–15144 50-GACC-30 50-CCGGAGGAGGA(GACC)-30 50-(GTCC)TCCCGTGAGGCCAAA-30 II 8558
18 6585–15144 50-GACC-30 50-CCGGAGGAGGA(GACC)-30 50-(GTCC)TCCCGTGAGGCCAAA-30 II 8558
Multiple-Deletion Patient
1 6577–15154 50-GAGG-30 50-TTCTTCGACCCCGCCG(GAGG)-30 50-CCAAATATCATTCTGAG-30 I 8576
2 6587–14285 50-GACCCC-30 50-CGCCGGAGGAGGA(GACCCC)-30 50-TCTCCTTCATAAA-30 I 7697
3 9417–13684 50-CCACC-30 50-CATACCAAGG(CCACC)-30 50-CTACTAAACCCC-30 I 4266
4 7406–12395 50-CCCCCCACCCTTACCAC-30 50-TATGGATG(CCCCCCACCCT_ACCAC)-30 50-(CCCCCCATCCTTACCAC)CCTCGT-30 II 4988
5 6457–14867 50-CTGATCCTCC-30 50-CCCCTCTTCGT(CTGATCCGTCC)-30 50-(CTGATCCTCC)AAATCACCACAGG-30 II 8409
6 6587–14285 50-GACCCC-30 50-CGCCGGAGGAGGA(GACCCC)-30 50-TCTCCTTCATAAA-30 I 7697
7 6572–12304 50-GCC-30 50-TTCTTCGACCCC(GCC)-30 50-CCAAAAATTTTGGT-30 I 5731
8 6585–15144 50-GACC-30 50-CCGGAGGAGGA(GACC)-30 50-(GTCC)TCCCGTGAGGCCAAA-30 II 8558
9 8482–13460 50-ACCTCCCTCACCA-30 50-AAACTACCACCT(ACCTCCCTCACCA)-30 50-TTGGCAGCCTAGCATT-30 I 4977
10 7367–12063 no repeat 50-TCCTAATAGTAGAAGAACCC-30 50-CCCTCATGTTCATACACCT-30 III 4694
11 6422–15208 50-AACCC-30 50-TTATCAATATAA(AACCC)-30 50-(ATCCC)ATACATTGGG-30 II 8785
12 6551–13852 50-ACCTCAAC-30 50-CTAACAGACCGCA(ACCTCAAC)-30 50-TACCTAACCAACAAA-30 I 7300
13 7114–13992 50-CCTAGACCTAACCT-30 50-TCAGGCTACAC(CCTAGACCAAACCT)-30 50-(CCTAGACCTAACCT)GACTAGAAAA-30 II 6877
14 8482–13460 50-ACCTCCCTCACCA-30 50-AAACTACCACCT(ACCTCCCTCACCA)-30 50-TTGGCAGCCTAGCATT-30 I 4977
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Table 1. Continued
Deletion Break Points Repeat 50 Sequence 30 Sequence
Class of
Deletion
Size
(bp)
15 7409–3688 50-CCCCACCCTAC-30 50-TATATGGATGCC(CCCCACCCTAC)-30 50-TAAACCCCATTAACG-30 I 6278
16 7204–13903 50-TATC-30 50-TTTCTCGGCC(TATC)-30 50-(TTTC)TCCAACATAC-30 II 6698
17 10071–14622 no repeat 50-AAACTTCGCCT-30 50-CCACAAACCCCATT-30 III 4550
18 7998–12300 no repeat 50-GACTCCTTGACGT-30 50-GGCCCCAAAAATTTT-30 III 4301
19 7201–14809 50-TCGGCCTCCCC-30 50-CACTTTC(TCGGCCTATCC) -30 50-(TCGACCTCCCC)ACCCCAT-30 II 7607
This table displays all 59 mtDNA deletions detected in single substantia nigra neurons between primers at nt 15896–15877 and nt 5855–5875. Repeat
sequences are shown in brackets and, where known, the deleted repeat shown in italics, imperfect bases within repeats are underlined, and missing bases
are indicated by an underscore.had no direct repeat (example shown in Figure 2). Where
there is an imperfect repeat, this allows identiﬁcation of
whether it is the 50 or the 30 end of the mtDNA molecule
that remains after formation of the deletion. Of the imper-
fect repeats, 15 out of 34 involved deletion of the 50 end,
and in 16 out of 34, the 30 end was deleted. Of interest, 2The Aout of 34 of the imperfect repeats were split in the middle
so that the ﬁrst half of the breakpoint corresponded to the
50 end and the second half with the 30 end, and for one of
the imperfect repeats, the deleted repeat couldnot be distin-
guished. An exampleof one such imperfect repeats is shown
in Figure 2E. The sequence proceeds through the repeat atTable 2. MtDNA Deletion Breakpoints from Substantia Nigra Neurons with Primers within the Major Arc that Include the D Loop
Deletion Breakpoints Repeat 50 Sequence 30 Sequence
Class of
Deletion
Size
(bp)
PD
1 6790–15918 no repeat 50-TTACAGTAGG-30 50-TTGTAAAGCCG-30 III 9128
2 7667–14359 no repeat 50-GATCACGCCC-30 50-CCACAGCACCA-30 III 6692
3 6537–13838 50-ACTACTAACAG-30 50-CACTAT(ACTACTAACAG)-30 50-(ACTTCTAACAG)CCCTAGACC-30 II 7301
4 7108–14688 50-CTACAACC-30 50-TTCTCAGG(CTACACCC) -30 50-(CTACAACC)ACGACCAAT-30 II 7580
5 6790–15918 no repeat 50-TTACAGTAGG-30 50-TTGTAAGCCG-30 III 9128
6 7128–14006 no repeat 50-GACCAAACCT-30 50-GACTAGAAAA-30 III 6889
7 6476–13777 50-ACA-30 50-GTCCTAATC(ACA)-30 50-ACAATCCCCC-30 I 7301
8 7188–14335 50-TTCCCACAAC-30 50-CTTTC(TTCCCACAAC)-30 50-(TTACCACAAC)CACCA-30 II 7147
Aged
1 6625–16074 50-TCACCC-30 50-ATTTTTCGG(TCACCC)-30 50-ATCAACAACA-30 I 9445
2 6759–15865 no repeat 50-CTAGGGTTTA-30 50-AAACAAAATA-30 III 9106
3 8232–15542 50-CCCCT-30 50-AGAATTAATT(CCCCT)-30 50-CCCCACATCAAG-30 I 7312
4 7821–13760 50-CCTCCC-30 50-TCATCGC(CCTCCC)-30 50-(CCCCCG)CATCCCCCTTC-30 II 5939
5 7265–16035 no repeat 50-CATCCTATCA-30 50-GGAAGCAGATT-30 III 8770
6 6790–15918 no repeat 50-TTTACAGTAGG-30 50-TTGTAAGCC-30 III 9128
7 6835–14380 50-CATCGCTAACCCCAC-30 50-CCATAAT(CATCGCTATCCCCAC)-30 50-(CATCGCTAACCCCAC)TAAAA-30 II 7545
8 7629–14813 50-ACTTCCCC-30 50-AAGACGCT(ACTTCCCC)-30 50-(ACCTCCCC)ACCCCATCC-30 II 7183
9 7808–14799 50-TCATCGACCTCCC-30 50-CTAGTCC(TCATCGCCCTCCC)-30 50-(TCATCGACCTCCC)CACCCC-30 II 6991
10 8904–14903 50-CCTAGCC-30 50-TTAAAAATGC(CCTAGCC)-30 50-ATGCACTACTCA-30 I 5999
Multiple-Deletion Patient
1 6501–13802 50-CAG_CCCT-30 50-CTATCTCTCC(CAGTCC_T)-30 50-(CAG_CCCT)CGCTGTCACT-30 II 7300
2 7125–14391 no repeat 50-CTAGACCAAA-30 50-CCACTAAAAC-30 III 7264
3 8232–15542 50-CCCCT-30 50-AATTAATT(CCCCT)-30 50-CCCCACATCA-30 I 7310
4 7414–15609 50-CCCTACCACAC-30 50-GCCCCCCA(CCCTACCACAC)-30 50-(CCCTAA_CAAAC)TAGGAGGCG-30 II 8195
5 6501–13802 50-CAG_CCCT-30 50-CTATCTCTCC(CAGTCC_T)-30 50-(CAG_CCCT)CGCTGTCACT-30 II 7300
6 6851–14816 50- TCATCGCTATCCCCACC-30 50-TACCATAA(TCATCGCTATCCCCACC)-30 50-(TCATCGACCTCCCCACC)CCATCCAAC-30 II 7965
7 7414–15609 50-CCCTACCACAC-30 50-GCCCCCCA(CCCTACCACAC)-30 50-(CCCTAA_CAAAC)TAGGAGGCG-30 II 8195
8 7212–14261 no repeat 50-TATCCGGAATGC-30 50-TCCTCCCGAA-30 III 7049
9 8601–15731 50-CTCCTCATTCTA-30 50-GCCGCAGTA(CTGATCATTCTA)-30 50-(CTCCTCATTCTA)ACCTGAATCG-30 II 7151
10 7458–11845 50-AAGC-30 50-AAAAGGAAGG(AATC)-30 50-(AAGC)CTCGCTAACC-30 II 4390
11 8656–14811 50-CACCCCA-30 50-GACTAATCA(CCACCCA)-30 50-(CACCCCA)TCCAACATCT-30 II 6163
12 7819–16071 50-CCCATC-30 50-TCATCG(CCATC)-30 50-(CCCATC)AACAACCGCT-30 II 8252
This table displays all 30 mtDNA deletions detected in single substantia nigra neurons with primers to include amplification of the 16,070 bp deletion
hotspot. Repeat sequences are shown in brackets, and where the deleted repeat is known, it is shown in italics; imperfect bases within repeats are
underlined, and missing bases are indicated by an underscore.merican Journal of Human Genetics 82, 228–235, January 2008 231
Figure 2. Sequence Chromatograms Displaying Examples of the Different Types of mtDNA Deletion Breakpoints Detected
This figure highlights the spectrum of different mtDNA deletion breakpoints detected in the neurons studied. Deletion A is from an aged
patient and has no repeat sequence, and deletion B has an 11 bp direct repeat and was found twice in the neurons of a PD patient.
Deletions C and D have imperfect repeat sequences. Deletion C is from the patient with multiple mtDNA deletions, and it is an example
of a deletion where the imperfect 50 repeat is deleted; in the 50 sequence, there is an insertion of a g at the position indicated. Deletion
D is from an aged control and is an example of where the 30 repeat is deleted; in the 30 sequence, the two bases highlighted are 50-CT-30.
Finally, deletion E shows a split repeat sequence where part of both the 50 and 30 repeat is deleted.the 50 end until base 7406 (a cytosine), and until this point,
the 30 sequence is deleted (the 30 sequence reads 50-CCC
CCCATCC-30); then, after this base, it is the 50 sequence
that is deleted, and the sequence proceeds from base
12395 (a thymine) (the 50 sequence reads 50-T_ACCAC-30).
The positions of the 50 and 30 breakpoints of the
detected deletions with repeats were plotted against the
frequency of the position (Figure 3). Although the 50
breakpoints have a slightly more complicated distribution,
it is noted that the 30 break points seem to cluster in three
distinct regions of the genome (at nt 11400–12400, nt
13400–14400, and nt 14800–16100) (Figure 3). In addi-
tion, there was no difference in the distribution of those
deletions without repeat sequences compared to those
with repeat sequences.
We compared a number of different parameters between
the deletions observed in the neurons from patients with
PD, from aged control subjects, and from the patient
with multiple deletions (Figure 4). We used a 2 3 3 Chi-
square test to compare the parameter repeats versus no re-
peats, and there was no signiﬁcant difference between the
groups (p ¼ 0.7683) (Figure 4A). When we compared the
next parameter, perfect versus imperfect repeats, a 2 3 3
Chi-square test was also used, and again there was no
signiﬁcant difference (p ¼ 0.1673) (Figure 4B). Finally, we
looked at the length of the repeat, and again there was
no signiﬁcant difference between the three groups (p >
0.10, analysis of variance [ANOVA]) (Figure 4C). Therefore,
for all parameters studied, there was no difference found in
the types of deletion breakpoint detected between the
three groups.
Our recent observations and those of several other
groups have highlighted that mtDNA deletions are fre-232 The American Journal of Human Genetics 82, 228–235, Januarquently observed in aging postmitotic tissues. These
mtDNA deletions must arise somatically because there
are different deletions in individual cells, an entirely dif-
ferent situation to those patients with single, large-scale
deletion disorders in which the deletion is present in
the oocyte and identical in all cells in which it can be de-
tected. These studies have conﬁrmed that there are high
levels of clonally expanded mtDNA deletions in individ-
ual neurons from the substantia nigra in aging and pa-
tients with PD. In this study, we have observed similarities
in the types of mtDNA deletion breakpoints occurring in
aging subjects, patients with PD, and a patient with mul-
tiple mtDNA deletions. The majority of deletion break-
points observed (~79%) in this study are ﬂanked by short
(3–17 bp) direct repeats. Of these, approximately 41% are
perfect, homologous repeats (class I deletions) and ap-
proximately 38% are imperfect (class II deletions). Only
approximately 20% of deletions involve no direct repeat
(class III deletions). In a study analyzing 263 pathogenic
human mtDNA deletions, the authors found that approx-
imately 60% were perfect repeats, approximately 30%
were imperfect repeats, and approximately 10% had no
direct repeat.8 These results are similar to those within
our study, suggesting a common mechanism for the gen-
eration of mtDNA deletions in humans. Although a study
identifying the deletion breakpoint characteristics of
patients with POLG1 or PEO1 mutations did not ﬁnd
evidence of perfect repeats of at least 10 bp, almost all
deletion breakpoints involved imperfect repeats of at least
2 bp, with homopolymeric runs being a common factor
associated with the breakpoints.7
The distribution of 50 end deletion breakpoints is spread
out with some peaks around the nt 6500, 7800, and 8400y 2008
Figure 3. Distribution of the mtDNA Deletion Breakpoints Detected from Substantia Nigra Neurons
This graph shows the distribution of the detected mtDNA deletion breakpoints within the genome. It is clear that although the 50 break-
points have a complicated distribution, the 30 breakpoints form three clusters. The breakpoint locations of the deletions from the PD
patients are shown in black, those from the aged neurons are in gray, and those from the patient with multiple mtDNA deletions are
hatched. MDP indicates a multiple-deletion patient.regions. For the 30 deletion breakpoints ends, there are
three clusters of where the breakpoints occur. There is no
difference in the distribution of deletion breakpoints
with no direct repeats. This suggests that the same funda-
mental mechanism exists to generate mtDNA deletions in-
volving both direct repeats and those without breakpoint
sequence homology.
The mechanism of mtDNA deletion formation remains
uncertain. It has beenpostulatedon thebasis of theClayton
strand-displacementmodel ofmtDNAreplication thatdele-
tions occur on thebasis of slipped-strand replication.9How-
ever, thismodel of replication has recently been challenged
withmtDNA replication occurring by a more conventional
replication mechanism in which leading-lagging-strand
DNA replication is coordinated.10 Recent studies have sug-
gested these models are now rather similar, and even in
the proposed leading-lagging-strand model, there is exten-
sive involvement of RNA, suggesting potentialmechanisms
of deletion formation during replication.11
Analysis of the breakpoints with imperfect repeats (n ¼
34) showed that in 47% of cases, the 30 end is deleted, com-
pared with 44% of cases, in which the 50 end is deleted. The
latter result is interesting because it has been previously
suggested that the 50 repeat sequence is rarely deleted.8
This previous bias suggested exclusion of intramolecularThe Arecombination as a method of mtDNA deletion genera-
tion. However, in our data, the chance of the 50 repeat
sequence being deleted is almost equal; therefore, on the
basis of this data, recombinationmight be a possible expla-
nation.
Previous studies have shown that the substantia nigra
is particularly prone to oxidative damage, and thus po-
tentially there will be high levels of oxidative damage to
the mitochondrial genome. This might result in either
impaired replication or, alternatively, repair of damaged
mtDNA, which could lead to deletion formation. Double-
strand breaks have previously been shown to be a possible
cause of deletion formation, as shown by the elegant ex-
periments by Moraes and colleagues in mouse after the
Pst1 restriction endonuclease was targeted to muscle.12
In conclusion, we have shown that the types of mtDNA
deletions that have clonally expanded in substantia nigra
neurons from patients with PD and age-matched control
subjects are similar to those from a patient with multi-
ple-deletion disorder and those reported in the literature
from patients with single mtDNA deletions. The break-
points of the deletions show similar characteristics and
distribution to those from patients with single mtDNA
deletions. These results indicate that the mechanism for
mtDNA deletions is the same, regardless of the clinicalmerican Journal of Human Genetics 82, 228–235, January 2008 233
Figure 4. Graphs Displaying the Characteristics of the mtDNA
Deletion Breakpoints within the Three Studied Groups
These graphs highlight the characteristics of the detected mtDNA
deletion breakpoints. (A) shows repeat versus no repeat. A Chi-
square test performed on these data showed the results were not
significantly different (p ¼ 0.7683). (B) displays perfect repeat
versus imperfect repeat. A Chi-square test performed on these
data showed that the results were not significantly different
(p ¼ 0.1673). (C) shows the size of all of the repeat sequences de-
tected, whether imperfect or perfect. An ANOVA test performed
on these data showed that the results were not significantly differ-
ent (p > 0.10). For (A) and (B), mtDNA deletions from PD patients
are in black, those from aged patients are in gray, and those from
the patient with multiple mtDNA deletions are hatched. MDP indi-
cates a multiple-deletion patient.234 The American Journal of Human Genetics 82, 228–235, Januaryscenario. At present, it is unknown what mechanism is
generating mtDNA deletions; however, because we found
high levels in substantia nigra neurons, cells shown to be
under considerable oxidative stress,13 it seems likely that
oxidative damage is involved. These current data conﬁrm
the previously reported high levels of mtDNA deletions in
substantia nigra neurons. Previous studies have shown
that higher levels of clonally expanded deletions are
seen in the COX-deﬁcient neurons, suggesting a func-
tional effect of these deletions, similar to that observed
in muscle.1,2,14
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